Advertisement
UK markets closed
  • FTSE 100

    8,317.59
    -21.64 (-0.26%)
     
  • FTSE 250

    20,770.93
    +139.63 (+0.68%)
     
  • AIM

    810.02
    +5.00 (+0.62%)
     
  • GBP/EUR

    1.1741
    +0.0004 (+0.04%)
     
  • GBP/USD

    1.2740
    +0.0042 (+0.33%)
     
  • Bitcoin GBP

    54,223.89
    +1,526.91 (+2.90%)
     
  • CMC Crypto 200

    1,444.13
    -23.97 (-1.63%)
     
  • S&P 500

    5,304.70
    +36.86 (+0.70%)
     
  • DOW

    39,069.20
    +3.94 (+0.01%)
     
  • CRUDE OIL

    77.72
    +0.85 (+1.11%)
     
  • GOLD FUTURES

    2,334.50
    -2.70 (-0.12%)
     
  • NIKKEI 225

    38,646.11
    -457.11 (-1.17%)
     
  • HANG SENG

    18,608.94
    -259.77 (-1.38%)
     
  • DAX

    18,693.37
    +2.05 (+0.01%)
     
  • CAC 40

    8,094.97
    -7.36 (-0.09%)
     

Global Spatial Genomics and Transcriptomics Market to Reach $503.1 Million by 2030

ReportLinker
ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, May 05, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Spatial Genomics and Transcriptomics Industry" - https://www.reportlinker.com/p06032958/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Spatial Genomics and Transcriptomics Market to Reach $503.1 Million by 2030

In the changed post COVID-19 business landscape, the global market for Spatial Genomics and Transcriptomics estimated at US$269.2 Million in the year 2022, is projected to reach a revised size of US$503.1 Million by 2030, growing at aCAGR of 8.1% over the period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 8.6% CAGR and reach US$288.4 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 4.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $78.8 Million, While China is Forecast to Grow at 7.4% CAGR

The Spatial Genomics and Transcriptomics market in the U.S. is estimated at US$78.8 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$85.7 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 5.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Select Competitors (Total 33 Featured)
- 10x Genomics
- Advanced Cell Diagnostics, Inc. (ACD)
- Cartana AB
- Dovetail Genomics
- Horizon Discovery Group plc
- Illumina, Inc.
- NanoString Technologies,
- Readcoor, inc.
- S2 Genomics, Inc.
- Seven Bridges Genomic


Read the full report: https://www.reportlinker.com/p06032958/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Spatial Genomics and Transcriptomics - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$ for
Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Spatial Genomics and
Transcriptomics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2014
through 2021 and % CAGR

Table 3: World 16-Year Perspective for Spatial Genomics and
Transcriptomics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Consumables by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2022 through 2030 and
% CAGR

Table 5: World Historic Review for Consumables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2014 through 2021 and % CAGR

Table 6: World 16-Year Perspective for Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Instruments by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2022 through 2030 and
% CAGR

Table 8: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Software by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2022 through 2030 and
% CAGR

Table 11: World Historic Review for Software by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Software by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Translational Research by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2022
through 2030 and % CAGR

Table 14: World Historic Review for Translational Research by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 15: World 16-Year Perspective for Translational Research
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Academic Customers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2022
through 2030 and % CAGR

Table 17: World Historic Review for Academic Customers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for Academic Customers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2022
through 2030 and % CAGR

Table 20: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 21: World 16-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 22: World Spatial Genomics and Transcriptomics Market
Analysis of Annual Sales in US$ for Years 2014 through 2030

Table 23: World Recent Past, Current & Future Analysis for
Spatial Transcriptomics by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2022
through 2030 and % CAGR

Table 24: World Historic Review for Spatial Transcriptomics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 25: World 16-Year Perspective for Spatial Transcriptomics
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 26: World Recent Past, Current & Future Analysis for
Spatial Genomics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2022
through 2030 and % CAGR

Table 27: World Historic Review for Spatial Genomics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 28: World 16-Year Perspective for Spatial Genomics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Spatial Genomics and Transcriptomics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2023 (E)
Table 29: USA Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Product - Consumables,
Instruments and Software - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 30: USA Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2014 through 2021 and % CAGR

Table 31: USA 16-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2014, 2023 & 2030

Table 32: USA Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by End-Use - Academic
Customers, Translational Research and Other End-Uses -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 33: USA Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Academic Customers, Translational
Research and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 34: USA 16-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Academic Customers, Translational Research and Other
End-Uses for the Years 2014, 2023 & 2030

Table 35: USA Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Technology - Spatial
Transcriptomics and Spatial Genomics - Independent Analysis of
Annual Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 36: USA Historic Review for Spatial Genomics and
Transcriptomics by Technology - Spatial Transcriptomics and
Spatial Genomics Markets - Independent Analysis of Annual Sales
in US$ for Years 2014 through 2021 and % CAGR

Table 37: USA 16-Year Perspective for Spatial Genomics and
Transcriptomics by Technology - Percentage Breakdown of Value
Sales for Spatial Transcriptomics and Spatial Genomics for the
Years 2014, 2023 & 2030

CANADA
Table 38: Canada Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Product - Consumables,
Instruments and Software - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 39: Canada Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2014 through 2021 and % CAGR

Table 40: Canada 16-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2014, 2023 & 2030

Table 41: Canada Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by End-Use - Academic
Customers, Translational Research and Other End-Uses -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 42: Canada Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Academic Customers, Translational
Research and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 43: Canada 16-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Academic Customers, Translational Research and Other
End-Uses for the Years 2014, 2023 & 2030

Table 44: Canada Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Technology - Spatial
Transcriptomics and Spatial Genomics - Independent Analysis of
Annual Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 45: Canada Historic Review for Spatial Genomics and
Transcriptomics by Technology - Spatial Transcriptomics and
Spatial Genomics Markets - Independent Analysis of Annual Sales
in US$ for Years 2014 through 2021 and % CAGR

Table 46: Canada 16-Year Perspective for Spatial Genomics and
Transcriptomics by Technology - Percentage Breakdown of Value
Sales for Spatial Transcriptomics and Spatial Genomics for the
Years 2014, 2023 & 2030

JAPAN
Spatial Genomics and Transcriptomics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 47: Japan Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Product - Consumables,
Instruments and Software - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 48: Japan Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2014 through 2021 and % CAGR

Table 49: Japan 16-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2014, 2023 & 2030

Table 50: Japan Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by End-Use - Academic
Customers, Translational Research and Other End-Uses -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 51: Japan Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Academic Customers, Translational
Research and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 52: Japan 16-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Academic Customers, Translational Research and Other
End-Uses for the Years 2014, 2023 & 2030

Table 53: Japan Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Technology - Spatial
Transcriptomics and Spatial Genomics - Independent Analysis of
Annual Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 54: Japan Historic Review for Spatial Genomics and
Transcriptomics by Technology - Spatial Transcriptomics and
Spatial Genomics Markets - Independent Analysis of Annual Sales
in US$ for Years 2014 through 2021 and % CAGR

Table 55: Japan 16-Year Perspective for Spatial Genomics and
Transcriptomics by Technology - Percentage Breakdown of Value
Sales for Spatial Transcriptomics and Spatial Genomics for the
Years 2014, 2023 & 2030

CHINA
Spatial Genomics and Transcriptomics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 56: China Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Product - Consumables,
Instruments and Software - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 57: China Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2014 through 2021 and % CAGR

Table 58: China 16-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2014, 2023 & 2030

Table 59: China Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by End-Use - Academic
Customers, Translational Research and Other End-Uses -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 60: China Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Academic Customers, Translational
Research and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 61: China 16-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Academic Customers, Translational Research and Other
End-Uses for the Years 2014, 2023 & 2030

Table 62: China Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Technology - Spatial
Transcriptomics and Spatial Genomics - Independent Analysis of
Annual Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 63: China Historic Review for Spatial Genomics and
Transcriptomics by Technology - Spatial Transcriptomics and
Spatial Genomics Markets - Independent Analysis of Annual Sales
in US$ for Years 2014 through 2021 and % CAGR

Table 64: China 16-Year Perspective for Spatial Genomics and
Transcriptomics by Technology - Percentage Breakdown of Value
Sales for Spatial Transcriptomics and Spatial Genomics for the
Years 2014, 2023 & 2030

EUROPE
Spatial Genomics and Transcriptomics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 65: Europe Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Geographic Region -
France, Germany, Italy, UK and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ for Years 2022
through 2030 and % CAGR

Table 66: Europe Historic Review for Spatial Genomics and
Transcriptomics by Geographic Region - France, Germany, Italy,
UK and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ for Years 2014 through 2021 and % CAGR

Table 67: Europe 16-Year Perspective for Spatial Genomics and
Transcriptomics by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2014, 2023 & 2030

Table 68: Europe Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Product - Consumables,
Instruments and Software - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 69: Europe Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2014 through 2021 and % CAGR

Table 70: Europe 16-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2014, 2023 & 2030

Table 71: Europe Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by End-Use - Academic
Customers, Translational Research and Other End-Uses -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 72: Europe Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Academic Customers, Translational
Research and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 73: Europe 16-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Academic Customers, Translational Research and Other
End-Uses for the Years 2014, 2023 & 2030

Table 74: Europe Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Technology - Spatial
Transcriptomics and Spatial Genomics - Independent Analysis of
Annual Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 75: Europe Historic Review for Spatial Genomics and
Transcriptomics by Technology - Spatial Transcriptomics and
Spatial Genomics Markets - Independent Analysis of Annual Sales
in US$ for Years 2014 through 2021 and % CAGR

Table 76: Europe 16-Year Perspective for Spatial Genomics and
Transcriptomics by Technology - Percentage Breakdown of Value
Sales for Spatial Transcriptomics and Spatial Genomics for the
Years 2014, 2023 & 2030

FRANCE
Spatial Genomics and Transcriptomics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 77: France Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Product - Consumables,
Instruments and Software - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 78: France Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2014 through 2021 and % CAGR

Table 79: France 16-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2014, 2023 & 2030

Table 80: France Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by End-Use - Academic
Customers, Translational Research and Other End-Uses -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 81: France Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Academic Customers, Translational
Research and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 82: France 16-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Academic Customers, Translational Research and Other
End-Uses for the Years 2014, 2023 & 2030

Table 83: France Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Technology - Spatial
Transcriptomics and Spatial Genomics - Independent Analysis of
Annual Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 84: France Historic Review for Spatial Genomics and
Transcriptomics by Technology - Spatial Transcriptomics and
Spatial Genomics Markets - Independent Analysis of Annual Sales
in US$ for Years 2014 through 2021 and % CAGR

Table 85: France 16-Year Perspective for Spatial Genomics and
Transcriptomics by Technology - Percentage Breakdown of Value
Sales for Spatial Transcriptomics and Spatial Genomics for the
Years 2014, 2023 & 2030

GERMANY
Spatial Genomics and Transcriptomics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 86: Germany Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Product - Consumables,
Instruments and Software - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 87: Germany Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2014 through 2021 and % CAGR

Table 88: Germany 16-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2014, 2023 & 2030

Table 89: Germany Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by End-Use - Academic
Customers, Translational Research and Other End-Uses -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 90: Germany Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Academic Customers, Translational
Research and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 91: Germany 16-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Academic Customers, Translational Research and Other
End-Uses for the Years 2014, 2023 & 2030

Table 92: Germany Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Technology - Spatial
Transcriptomics and Spatial Genomics - Independent Analysis of
Annual Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 93: Germany Historic Review for Spatial Genomics and
Transcriptomics by Technology - Spatial Transcriptomics and
Spatial Genomics Markets - Independent Analysis of Annual Sales
in US$ for Years 2014 through 2021 and % CAGR

Table 94: Germany 16-Year Perspective for Spatial Genomics and
Transcriptomics by Technology - Percentage Breakdown of Value
Sales for Spatial Transcriptomics and Spatial Genomics for the
Years 2014, 2023 & 2030

ITALY
Table 95: Italy Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Product - Consumables,
Instruments and Software - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 96: Italy Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2014 through 2021 and % CAGR

Table 97: Italy 16-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2014, 2023 & 2030

Table 98: Italy Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by End-Use - Academic
Customers, Translational Research and Other End-Uses -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 99: Italy Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Academic Customers, Translational
Research and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 100: Italy 16-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Academic Customers, Translational Research and Other
End-Uses for the Years 2014, 2023 & 2030

Table 101: Italy Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Technology - Spatial
Transcriptomics and Spatial Genomics - Independent Analysis of
Annual Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 102: Italy Historic Review for Spatial Genomics and
Transcriptomics by Technology - Spatial Transcriptomics and
Spatial Genomics Markets - Independent Analysis of Annual Sales
in US$ for Years 2014 through 2021 and % CAGR

Table 103: Italy 16-Year Perspective for Spatial Genomics and
Transcriptomics by Technology - Percentage Breakdown of Value
Sales for Spatial Transcriptomics and Spatial Genomics for the
Years 2014, 2023 & 2030

UNITED KINGDOM
Spatial Genomics and Transcriptomics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United Kingdom
for 2023 (E)
Table 104: UK Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Product - Consumables,
Instruments and Software - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 105: UK Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2014 through 2021 and % CAGR

Table 106: UK 16-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2014, 2023 & 2030

Table 107: UK Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by End-Use - Academic
Customers, Translational Research and Other End-Uses -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 108: UK Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Academic Customers, Translational
Research and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 109: UK 16-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Academic Customers, Translational Research and Other
End-Uses for the Years 2014, 2023 & 2030

Table 110: UK Recent Past, Current & Future Analysis for
Spatial Genomics and Transcriptomics by Technology - Spatial
Transcriptomics and Spatial Genomics - Independent Analysis of
Annual Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 111: UK Historic Review for Spatial Genomics and
Transcriptomics by Technology - Spatial Transcriptomics and
Spatial Genomics Markets - Independent Analysis of Annual Sales
in US$ for Years 2014 through 2021 and % CAGR

Table 112: UK 16-Year Perspective for Spatial Genomics and
Transcriptomics by Technology - Percentage Breakdown of Value
Sales for Spatial Transcriptomics and Spatial Genomics for the
Years 2014, 2023 & 2030

REST OF EUROPE
Table 113: Rest of Europe Recent Past, Current & Future
Analysis for Spatial Genomics and Transcriptomics by Product -
Consumables, Instruments and Software - Independent Analysis of
Annual Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 114: Rest of Europe Historic Review for Spatial Genomics
and Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2014 through 2021 and % CAGR

Table 115: Rest of Europe 16-Year Perspective for Spatial
Genomics and Transcriptomics by Product - Percentage Breakdown
of Value Sales for Consumables, Instruments and Software for
the Years 2014, 2023 & 2030

Table 116: Rest of Europe Recent Past, Current & Future
Analysis for Spatial Genomics and Transcriptomics by End-Use -
Academic Customers, Translational Research and Other End-Uses -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 117: Rest of Europe Historic Review for Spatial Genomics
and Transcriptomics by End-Use - Academic Customers,
Translational Research and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ for Years 2014 through 2021 and
% CAGR

Table 118: Rest of Europe 16-Year Perspective for Spatial
Genomics and Transcriptomics by End-Use - Percentage Breakdown
of Value Sales for Academic Customers, Translational Research
and Other End-Uses for the Years 2014, 2023 & 2030

Table 119: Rest of Europe Recent Past, Current & Future
Analysis for Spatial Genomics and Transcriptomics by Technology -
Spatial Transcriptomics and Spatial Genomics - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 120: Rest of Europe Historic Review for Spatial Genomics
and Transcriptomics by Technology - Spatial Transcriptomics and
Spatial Genomics Markets - Independent Analysis of Annual Sales
in US$ for Years 2014 through 2021 and % CAGR

Table 121: Rest of Europe 16-Year Perspective for Spatial
Genomics and Transcriptomics by Technology - Percentage
Breakdown of Value Sales for Spatial Transcriptomics and
Spatial Genomics for the Years 2014, 2023 & 2030

ASIA-PACIFIC
Spatial Genomics and Transcriptomics Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Asia-Pacific for
2023 (E)
Table 122: Asia-Pacific Recent Past, Current & Future Analysis
for Spatial Genomics and Transcriptomics by Product -
Consumables, Instruments and Software - Independent Analysis of
Annual Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 123: Asia-Pacific Historic Review for Spatial Genomics
and Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2014 through 2021 and % CAGR

Table 124: Asia-Pacific 16-Year Perspective for Spatial
Genomics and Transcriptomics by Product - Percentage Breakdown
of Value Sales for Consumables, Instruments and Software for
the Years 2014, 2023 & 2030

Table 125: Asia-Pacific Recent Past, Current & Future Analysis
for Spatial Genomics and Transcriptomics by End-Use - Academic
Customers, Translational Research and Other End-Uses -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 126: Asia-Pacific Historic Review for Spatial Genomics
and Transcriptomics by End-Use - Academic Customers,
Translational Research and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ for Years 2014 through 2021 and
% CAGR

Table 127: Asia-Pacific 16-Year Perspective for Spatial
Genomics and Transcriptomics by End-Use - Percentage Breakdown
of Value Sales for Academic Customers, Translational Research
and Other End-Uses for the Years 2014, 2023 & 2030

Table 128: Asia-Pacific Recent Past, Current & Future Analysis
for Spatial Genomics and Transcriptomics by Technology -
Spatial Transcriptomics and Spatial Genomics - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 129: Asia-Pacific Historic Review for Spatial Genomics
and Transcriptomics by Technology - Spatial Transcriptomics and
Spatial Genomics Markets - Independent Analysis of Annual Sales

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032958/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001